Nomura Holdings
CRL icon

Nomura Holdings’s Charles River Laboratories CRL Stock Holding History

Nomura Holdings’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,100,000
Closed -$167M – 1905
2025
Q2 		$167M Buy
1,100,000
+500,000
+83% +$66.7M 0.35% 54
2025
Q1 		$90.3M Buy
+600,000
New +$101M 0.17% 92
2024
Q3 		– Sell
-12,500
Closed -$2.58M – 1607
2024
Q2 		$2.58M Buy
+12,500
New +$2.83M ﹤0.01% 863

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings's CRL Position: Q1 2026 in Review

Nomura Holdings increased its Charles River Laboratories (CRL) stake by 60% in Q1 2026, buying an estimated $316K and bringing the position to 4,550 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

Nomura Holdings first reported a position in CRL in Q2 2013 and has held it in 25 quarters since. The position peaked at $238M in Q2 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Nomura Holdings held 4,550 shares of Charles River Laboratories worth $785K as of Q1 2026.
  • Nomura Holdings bought 1,707 Charles River Laboratories shares in Q1 2026, an estimated $316K.
  • Charles River Laboratories made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1235 holding.
  • Nomura Holdings first reported a position in Charles River Laboratories in Q2 2013 and has held it in 25 quarters since.
  • Nomura Holdings's Charles River Laboratories position peaked at $238M in Q2 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.